Mycophenolate mofetil has been successfully used for the treatment of several autoimmune and inflammatory skin diseases.1 Although multiple studies support the use of mycophenolate mofetil in systemic lupus erythematosus (LE), only 3 cases describing its use in chronic cutaneous LE without systemic involvement have been reported.2,3 We discuss the role of mycophenolate mofetil in the management of multiple variants of cutaneous LE with associated systemic disease (Table 1).
Hanjani NM, Nousari CH. Mycophenolate Mofetil for the Treatment of Cutaneous Lupus Erythematosus With Smoldering Systemic Involvement. Arch Dermatol. 2002;138(12):1616. doi:10.1001/archderm.138.12.1613
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: